Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain Visibility

In this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the EU directive on falsified medicines will have the generics market and his top tips for improving supply chain visibility. Have... To continue reading this story Click Here